NC-stat — DPNCheck Fast, accurate and quantitative test that may be used to evaluate peripheral neuropathies such as DPN. It may aid in the early detection, confirmation, and monitoring of DPN. It measures sural nerve conduction velocity – a standard biomarker for subclinical and symptomatic DPN. It is sensitive and specific for …

We asked our readers to give us feedback into how much they knew about GLP-1 Analogs and a broad cross-section replied. Take a look at 5 of the questions and how your colleagues answered…. It appears that most of you knew that a large amount of GLP-1 production is lost …

Steve and Andrew came back with a ton of new data on GLP-1 Agonist therapies from the 71st Scientific Sessions of the ADA. We turned over these articles, abstracts, posters and presentations to our interns for them to get down to what really matters. They have three articles focusing on …

In order to increase compliance and improve efficacy, there is an experimental long acting exenatide once monthly injectable suspension in the pipeline. This long acting formulation is currently in phase-2 trial and has showed promising results in controlling A1C in type 2 diabetes patients….

The investigational drug Lyxumia® (lixisenatide), a once daily GLP-1 agonist, is making progress as a newer drug in this increasingly crowded class of drugs.  Data from four studies of the GetGoal Phase III clinical program was presented at the ADA sessions….

Adding Insulin to Metformin and Liraglutide: A New Sequence of Medication Therapy for Type-2 Diabetes Patients A new clinical study shows for the first time that the addition of long-acting insulin to the medication regimen of Metformin plus Victoza (liraglutide) allowed patients to reach an A1c goal of less-than-7% with …

While I was talking to a large group of employees on the west coast of Florida, I made the comment that if you are over 40 and have a family history of diabetes, overweight, hypertension or have elevated lipids, you should get an A1c test at your next physical. Apparently …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. PJ was referred to the diabetes centre by a physician in the infectious diseases department of a large metropolitan hospital. Mrs. PJ is an 80-year-old woman who has had type …

This week we present PART 3 of our series on the Diagnosis and Management of Diabetic Eye Disease, focusing on cataracts and keratopathy….

BYDUREON™ Receives Marketing Authorization in Europe BYDUREON showed statistically significant improvements in glycemic control based on reduction of A1C (a measure of average blood sugar over three months) between 1.5 and 1.9 percent after six months.